These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 28693428)

  • 1. Inverse probability of treatment-weighted competing risks analysis: an application on long-term risk of urinary adverse events after prostate cancer treatments.
    Bolch CA; Chu H; Jarosek S; Cole SR; Elliott S; Virnig B
    BMC Med Res Methodol; 2017 Jul; 17(1):93. PubMed ID: 28693428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both.
    Jarosek SL; Virnig BA; Chu H; Elliott SP
    Eur Urol; 2015 Feb; 67(2):273-80. PubMed ID: 25217421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Patient Burden of Bladder Outlet Obstruction after Prostate Cancer Treatment.
    Liberman D; Jarosek S; Virnig BA; Chu H; Elliott SP
    J Urol; 2016 May; 195(5):1459-1463. PubMed ID: 26682759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propensity-Weighted Comparison of Long-Term Risk of Urinary Adverse Events in Elderly Women Treated For Cervical Cancer.
    Elliott SP; Fan Y; Jarosek S; Chu H; Downs L; Dusenbery K; Geller MA; Virnig BA
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):586-93. PubMed ID: 25890845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time Course and Accumulated Risk of Severe Urinary Adverse Events After High- Versus Low-Dose-Rate Prostate Brachytherapy With or Without External Beam Radiation Therapy.
    Tward JD; Jarosek S; Chu H; Thorpe C; Shrieve DC; Elliott S
    Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1443-1453. PubMed ID: 27325475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.
    Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR;
    J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
    Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
    Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
    Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
    Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.
    Satkunasivam R; Kim AE; Desai M; Nguyen MM; Quinn DI; Ballas L; Lewinger JP; Stern MC; Hamilton AS; Aron M; Gill IS
    J Urol; 2015 Aug; 194(2):378-85. PubMed ID: 25711194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
    Nieder AM; Porter MP; Soloway MS
    J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study.
    Nam RK; Cheung P; Herschorn S; Saskin R; Su J; Klotz LH; Chang M; Kulkarni GS; Lee Y; Kodama RT; Narod SA
    Lancet Oncol; 2014 Feb; 15(2):223-31. PubMed ID: 24440474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Radiation Therapy Oncology Group grade 4 urinary adverse events after radiotherapy for prostate cancer.
    Mayer EN; Tward JD; Bassett M; Lenherr SM; Hotaling JM; Brant WO; Lowrance WT; Myers JB
    BJU Int; 2017 May; 119(5):700-708. PubMed ID: 27469289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study.
    Mohamad O; Tabuchi T; Nitta Y; Nomoto A; Sato A; Kasuya G; Makishima H; Choy H; Yamada S; Morishima T; Tsuji H; Miyashiro I; Kamada T
    Lancet Oncol; 2019 May; 20(5):674-685. PubMed ID: 30885458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of initial local therapy on survival in men later receiving chemotherapy for prostate cancer: a population-based, propensity-weighted multivariable analysis.
    Zabell JR; Adejoro O; Jarosek SL; Elliott SP; Konety BR
    World J Urol; 2016 Oct; 34(10):1397-403. PubMed ID: 26914817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Risk of Urinary Adverse Events in Curatively Treated Patients With Rectal Cancer: A Population-Based Analysis.
    Kwaan MR; Fan Y; Jarosek S; Elliott SP
    Dis Colon Rectum; 2017 Jul; 60(7):682-690. PubMed ID: 28594717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascertainment of postprostatectomy radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database.
    Wang K; Sheets NC; Basak R; Chen RC
    Cancer; 2016 Oct; 122(19):3069-74. PubMed ID: 27352280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and Skeletal-related Events Following Localized Prostate Cancer Treatment: Role of Surgery, Radiotherapy, and Androgen Deprivation.
    Wallis CJ; Mahar AL; Satkunasivam R; Herschorn S; Kodama RT; Lee Y; Kulkarni GS; Narod SA; Nam RK
    Urology; 2016 Nov; 97():145-152. PubMed ID: 27502032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients.
    Cozzarini C; Fiorino C; Deantoni C; Briganti A; Fodor A; La Macchia M; Noris Chiorda B; Rancoita PM; Suardi N; Zerbetto F; Calandrino R; Montorsi F; Di Muzio N
    Eur Urol; 2014 Dec; 66(6):1024-30. PubMed ID: 24985964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The characteristics of bladder cancer after radiotherapy for prostate cancer.
    Abern MR; Dude AM; Tsivian M; Coogan CL
    Urol Oncol; 2013 Nov; 31(8):1628-34. PubMed ID: 22575239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vesicourethral anastomotic stricture following radical prostatectomy with or without postoperative radiotherapy].
    Muñoz D; Vicens A; García-Montes F
    Actas Urol Esp; 2011 May; 35(5):277-81. PubMed ID: 21392853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.